TORI LIGHTNER: Open Payments
NPI 1134701808 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,919 in 143 payments from 13 companies in 2025. Trend: 2023 $1,106 · 2024 $1,280 · 2025 $1,919
Food & beverage: $1,919
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 30 | $418 |
| Neurocrine BioSciences, Inc. | 18 | $251 |
| Janssen Pharmaceuticals, Inc | 16 | $217 |
| E.R. Squibb & Sons, L.L.C. | 14 | $198 |
| Lundbeck LLC | 17 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $167 |
| ABBVIE INC. | 16 | $163 |
| Axsome Therapeutics, Inc. | 10 | $143 |
| Alkermes, Inc. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
Products named: REXULTI, INGREZZA, COBENFY, CAPLYTA, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across PA — which companies pay providers there.
